Animal Health Global Innovation
Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our internal colleagues in human health and with many external partners to deliver breakthrough animal health therapies, and we maximize our ability to enhance the wellbeing of animals by focusing on areas that will impact the greatest number of animals. Our broad portfolio of veterinary therapeutics, parasiticides and vaccines reflects Boehringer Ingelheim’s strong commitment to delivering value through innovation.
In Global Innovation, we work across diseases and species to deliver a robust pipeline of safe and effective vaccines for companion animals and livestock. We bring together broad expertise in vaccinology, molecular biology, bioprocess, assay and clinical development. With strong connections with academic institutes and startups, we leverage cutting edge science, technology and experience to deliver value through innovation that improves the health and welfare of animals.
We are committed to not only updating vaccine strains as veterinary diseases evolve and spread due to globalization and climate change, but also finding breakthrough innovative vaccine solutions for emerging and transboundary diseases, bacterial diseases and development of mucosal immunity. We are continually integrating new biotechnologies to enhance the quality of our vaccines.